💊 Fármacos A-Z 🧬 Dianas 🛠 Herramientas 📚 Guías
Todos los fármacos Clases de fármacos Áreas terapéuticas Efectos Secundarios
Guías Glosario Línea de tiempo
Comparaciones Recorridos de fármacos Familias farmacológicas
🇺🇸 English 🇰🇷 한국어 🇯🇵 日本語 🇨🇳 中文简体 🇪🇸 Español 🇧🇷 Português 🇮🇳 हिन्दी 🇸🇦 العربية 🇫🇷 Français 🇷🇺 Русский 🇩🇪 Deutsch 🇹🇷 Türkçe 🇻🇳 Tiếng Việt 🇮🇩 Bahasa Indonesia 🇹🇭 ไทย

Nitroglycerin

CHEMBL730 Phase 4 Aprobado Small molecule
Half-Life
1-4 minutes
Bioavailability
—
Protein Binding
—
Molecular Weight
227.1 g/mol
LogP
1.6
Phase
4

A fast-acting medication that widens blood vessels to quickly relieve chest pain caused by insufficient blood supply to the heart.

Peso molecular

227,0870 g/mol

LogP

1,60

TPSA

165,00 Ų

Regla de cinco de Lipinski

Cumple

Áreas terapéuticas

Artritis reumatoide Cáncer colorrectal Cáncer de mama Cáncer de ovario Cáncer de páncreas Cáncer de próstata Cáncer de pulmón de células no pequeñas Cáncer de tiroides Cáncer de vejiga Diabetes tipo 2 Dolor crónico Enfermedad cardiovascular Enfermedad pulmonar obstructiva crónica Enfermedad renal crónica Enfermedad respiratoria Esquizofrenia Glaucoma Hiperlipidemia Hipertensión Ictus Insuficiencia cardíaca Lupus eritematoso sistémico Manejo del dolor Migraña Osteoporosis

Clases de fármacos

C — C - Sistema cardiovascular

Mecanismo de acción

Nitric oxide donor causing venous and arterial vasodilation.

Pharmacokinetics (PK)

Half-Life 1-4 minutes

Pharmacodynamics (PD)

Mecanismo

Nitric oxide donor causing venous and arterial vasodilation.

Estructura 2D

SVG PNG

Cite this structure


                        

                            
                            
                        

                    

                


                
                

                    

                    

                        
Embed this structure

                        

                        

                            
                            
                        

                    

                

                

                
                

                    
SMILES

                    
O=[N+]([O-])OCC(CO[N+](=O)[O-])O[N+](=O)[O-]

                

                

                
                

                    
InChI

                    
InChI=1S/C3H5N3O9/c7-4(8)13-1-3(15-6(11)12)2-14-5(9)10/h3H,1-2H2

                

                

                

                    
                    

                        
Molecular Formula

                        
C3H5N3O9

                    

                    
                    

                        
HBD / HBA

                        
- / 9

                    

                    
                    

                        
Enlaces Rotables

                        
5

                    

                    
                    
                    

                        
Átomos Pesados

                        
15

                    

                    
                

            


            
            

                
                

                    
                    

                        

                            PDE5A (Fosfodiesterasa 5 (PDE5))
                            Other
                        

                        
                        Primary Target
                        
                    

                    
                

                
            


            
            

                
                

                    
                    
                        

                            

  
  Major


                            
                                Nitroglycerin + Sildenafil
                            
                        

                        
                        
Combining sildenafil with nitrates causes profound, potentially fatal hypotension; this combination is absolutely contraindicated.

                        
                    
                    
                

                
            


            
            

                
                


    
    
        
    
    
    
No side effects recorded

    
    
Side effect data is not yet available for this drug.

    



                
            


            
            
            

                
Preguntas frecuentes

                

                    
                    

                        
                        

                            
A fast-acting medication that widens blood vessels to quickly relieve chest pain caused by insufficient blood supply to the heart.

                        

                    

                    

                    

                    
                    

                        
                        

                            
Nitric oxide donor causing venous and arterial vasodilation.

                        

                    

                    

                    
                    

                        
                        

                            
Key pharmacokinetic parameters for Nitroglycerin: Half-life: 1-4 minutes.

                        

                    

                    

                    

                        
                        

                            
Yes, Nitroglycerin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

                        

                    

                

            

            

            
            

            
            
            

                
Related Drugs


                
                

                    
Same Drug Class

                    

                        
                        
                            Atorvastatin
                            Small molecule
                        
                        
                        
                            Amlodipine
                            Small molecule
                        
                        
                        
                            Lisinopril
                            Small molecule
                        
                        
                        
                            Metoprolol
                            Small molecule
                        
                        
                    

                

                

                
                
                
            

            

            
            
{# References & Data Sources section for drug detail pages.
   Renders standard pharmacological database links plus the drug's data_sources field. #}


    
References & Data Sources

    
    
        
        
  • 
            
            
                ChEMBL — European Bioinformatics Institute (EBI).
                CHEMBL730.
                Open-access bioactivity database.
            
        
    • 
        
        
        
  • 
            
            
                PubChem — National Center for Biotechnology Information (NCBI).
                CID 4510.
                Chemical information database.
            
        
    • 
        
        
        
        
    

    
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.




        


        
        
    


    



    
Aviso médico

    

        This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.
    

    

        Data sources:
        ChEMBL,
        PubChem,
        DailyMed.